CRDF
Price
$3.18
Change
+$0.27 (+9.28%)
Updated
Dec 24 closing price
Capitalization
214.21M
63 days until earnings call
Intraday BUY SELL Signals
FDMT
Price
$8.10
Change
+$0.20 (+2.53%)
Updated
Dec 24 closing price
Capitalization
462.79M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRDF vs FDMT

Header iconCRDF vs FDMT Comparison
Open Charts CRDF vs FDMTBanner chart's image
Cardiff Oncology
Price$3.18
Change+$0.27 (+9.28%)
Volume$1.36M
Capitalization214.21M
4D Molecular Therapeutics
Price$8.10
Change+$0.20 (+2.53%)
Volume$613.91K
Capitalization462.79M
CRDF vs FDMT Comparison Chart in %
CRDF
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRDF vs. FDMT commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a Buy and FDMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (CRDF: $3.18 vs. FDMT: $8.10)
Brand notoriety: CRDF and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 153% vs. FDMT: 58%
Market capitalization -- CRDF: $214.21M vs. FDMT: $462.79M
CRDF [@Biotechnology] is valued at $214.21M. FDMT’s [@Biotechnology] market capitalization is $462.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, CRDF is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 6 TA indicator(s) are bullish while FDMT’s TA Score has 4 bullish TA indicator(s).

  • CRDF’s TA Score: 6 bullish, 3 bearish.
  • FDMT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRDF is a better buy in the short-term than FDMT.

Price Growth

CRDF (@Biotechnology) experienced а +31.95% price change this week, while FDMT (@Biotechnology) price change was -12.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

CRDF is expected to report earnings on Feb 26, 2026.

FDMT is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FDMT($463M) has a higher market cap than CRDF($214M). FDMT YTD gains are higher at: 45.422 vs. CRDF (-26.728). CRDF has higher annual earnings (EBITDA): -53.33M vs. FDMT (-222.95M). FDMT has more cash in the bank: 305M vs. CRDF (60.6M). CRDF has less debt than FDMT: CRDF (1.01M) vs FDMT (22.3M). CRDF has higher revenues than FDMT: CRDF (501K) vs FDMT (120K).
CRDFFDMTCRDF / FDMT
Capitalization214M463M46%
EBITDA-53.33M-222.95M24%
Gain YTD-26.72845.422-59%
P/E RatioN/AN/A-
Revenue501K120K418%
Total Cash60.6M305M20%
Total Debt1.01M22.3M5%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRDFFDMT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRDF
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LJUIF0.40N/A
N/A
SSY GROUP LTD
SOSAF1.01N/A
N/A
SoSTravel.com S.p.A
SGLOF17.82N/A
N/A
FOOD & LIFE COS LTD.
TNXXF131.00N/A
N/A
Talanx AG
CSTAF11.52N/A
N/A
Constellation Acquisition Corp I

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
+9.28%
SYRE - CRDF
42%
Loosely correlated
-0.54%
FDMT - CRDF
41%
Loosely correlated
+2.53%
NRIX - CRDF
40%
Loosely correlated
+0.36%
IBRX - CRDF
40%
Loosely correlated
+1.90%
ORMP - CRDF
39%
Loosely correlated
+6.78%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+2.53%
RGNX - FDMT
48%
Loosely correlated
+0.77%
CLDX - FDMT
45%
Loosely correlated
+0.94%
IDYA - FDMT
44%
Loosely correlated
+0.76%
SYRE - FDMT
43%
Loosely correlated
-0.54%
KURA - FDMT
43%
Loosely correlated
+2.50%
More